Optum Ventures
Investor profile
Venture capital
Deals
8
distinct rounds
Companies
7
backed
Active span
2017–2024
8 yrs
Total round €
€321M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Aescuvest1
- Anthem1
- BIONIQ Capital1
- BlackRock Innovation Capital1
- Blue Cross1
- Blue Venture Fund1
- Capital3001
- Cure Capital1
- Endeavour Vision1
- Frist Cressey1
- GreatPoint Ventures1
- GV1
- IDInvest Partners1
- Lauxera Capital Partners1
- MTIP AG1
- Oxford Sciences Innovation1
- PFM Health Sciences1
- Pictet Alternative Advisors1
- Plug & Play Growth Fund1
- ProAssurance Corp1
- Relyens Group1
- Sequoia Capital1
- Surgical.AI1
- Symbiotic Capital1
- Vesalius Biocapital Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Caresyntax | Germany | 1 | €164M |
| Vim | Israel | 1 | €51M |
| Kaia Health | Germany | 2 | €30M |
| Ultromics | UK | 1 | €28M |
| Lumeon | UK | 1 | €25M |
| Oxford VR | UK | 1 | €12M |
| LetsGetChecked | Ireland | 1 | €11M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Caresyntax | Series C | €164M | 2024-08 |
| Vim | Other | €51M | 2021-05 |
| Ultromics | Series B | €28M | 2021-08 |
| Lumeon | Series D+ | €25M | 2020-08 |
| Kaia Health | Series B | €23M | 2020-06 |
| Oxford VR | Series A | €12M | 2020-12 |
| LetsGetChecked | Series A | €11M | 2017-12 |
| Kaia Health | Series A | €7.3M | 2019-09 |